Literature DB >> 14060117

ABILITY OF VENOMS TO RENDER SQUID AXONS SENSITIVE TO CURARE AND ACETYLCHOLINE.

P ROSENBERG, T R PODLESKI.   

Abstract

Entities:  

Keywords:  ACETYLCHOLINE; AXONS; CURARE; EXPERIMENTAL LAB STUDY; MOLLUSCA; PHARMACOLOGY; VENOMS

Mesh:

Substances:

Year:  1963        PMID: 14060117     DOI: 10.1016/0006-3002(63)90584-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  7 in total

1.  Similarities between active sites of acetylcholine receptor and acetylcholinesterase tested with quinolinium ions.

Authors:  T R Podleski; D Nachmansohn
Journal:  Proc Natl Acad Sci U S A       Date:  1966-09       Impact factor: 11.205

2.  Similarity of effects of oxygen, sulfur, and selenium isologs on the acetylcholine receptor in excitable membranes of junctions and axons.

Authors:  P Rosenberg; H G Mautner; D Nachmansohn
Journal:  Proc Natl Acad Sci U S A       Date:  1966-04       Impact factor: 11.205

3.  Chemical control of excitable membranes during electrical activity.

Authors:  D Nachmansohn
Journal:  Protoplasma       Date:  1967       Impact factor: 3.356

4.  Cholinesterase activity per unit surface area of conducting membranes.

Authors:  M Brzin; W D Dettbarn; P Rosenberg; D Nachmansohn
Journal:  J Cell Biol       Date:  1965-08       Impact factor: 10.539

5.  Penetration of sugars, steroids, amino acids, and other organic compounds into the interior of the squid giant axon.

Authors:  F C Hoskin; P Rosenberg
Journal:  J Gen Physiol       Date:  1965-09       Impact factor: 4.086

6.  Fine structural alterations associated with venom action on squid giant nerve fibers.

Authors:  R Martin; P Rosenberg
Journal:  J Cell Biol       Date:  1968-02       Impact factor: 10.539

7.  ALTERATION OF ACETYLCHOLINE PENETRATION INTO, AND EFFECTS ON, VENOM-TREATED SQUID AXONS BY PHYSOSTIGMINE AND RELATED COMPOUNDS.

Authors:  F C HOSKIN; P ROSENBERG
Journal:  J Gen Physiol       Date:  1964-07       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.